Package Leaflet: Information for the User
Medicinal Liquid Oxygen VIVISOL 99.5% v/v, Cryogenic Medicinal Gas
Read the entire package leaflet carefully before starting to use this medication, as it contains important information for you.
Contents of the Package Leaflet
Medicinal oxygen contains oxygen, which is essential for life. Oxygen therapy can be performed under normal pressure and high pressure.
Normal Pressure Oxygen Therapy(normobaric oxygen therapy)
Normal pressure oxygen therapy can be used to treat:
High-Pressure Oxygen Therapy(hyperbaric oxygen therapy)
High-pressure oxygen therapy should only be administered by qualified healthcare professionals to avoid the risk of injury from strong pressure fluctuations. High-pressure oxygen therapy can be used to:
For supportive treatment in cases of tissue necrosisdue to infected wounds with gas-producing bacteria
Do not use Medicinal Liquid Oxygen VIVISOL
Oxygen should not be used at pressures above atmospheric pressure (hyperbaric oxygen therapy) in cases of untreated or undrained pneumothorax. Pneumothorax occurs due to the accumulation of air in the thoracic cavity between the two lung membranes. If you have ever had pneumothorax, inform your doctor.
Warnings and Precautions
Consult your doctor or pharmacist before starting to use Medicinal Liquid Oxygen VIVISOL:
Hyperbaric Oxygen Therapy
Before starting high-pressure oxygen therapy, inform your doctor if you have:
Children
In premature and newborn babies, oxygen therapy can cause eye damage (retinopathy of prematurity). Your doctor will determine the appropriate oxygen concentration to administer to ensure your baby receives the correct treatment.
When using oxygen, there is a higher risk of fire ignition.
Using Medicinal Liquid Oxygen VIVISOL with other medications
Inform your doctor or pharmacist if you are using, have recently used, or may need to use any other medication.
If you are taking or have been prescribed bleomycin (to treat cancer), amiodarone (to treat heart disease), or nitrofurantoin (to treat infections), inform your doctor before using oxygen, as there is a possibility of toxic effects on the lungs.
Oxygen can exacerbate previous lung damage caused by the pesticide Paraquat. In case of Paraquat poisoning, additional oxygen administration should be avoided as much as possible.
Using Medicinal Liquid Oxygen VIVISOL with food, beverages, and alcohol
Do not consume alcoholwhile using this medication. Alcohol can cause respiratory depression.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using any medication.
High-pressure oxygen therapy (hyperbaric oxygen therapy) should only be used during pregnancy or if you think you may be pregnant if it is strictly necessary. Inform the treating doctor or specialist if this is the case.
Driving and using machines
Normal pressure medicinal oxygen (normobaric oxygen therapy) does not affect the ability to drive or use machines.
After receiving high-pressure oxygen therapy (hyperbaric oxygen therapy), you may experience visual and auditory disturbances that can affect your ability to drive and use machines.
Follow your doctor's instructions for administering this medication exactly. If in doubt, consult your doctor or pharmacist again.
Never change the concentration of oxygen administration or that of your child.
Dosage
Normal Pressure Oxygen Therapy(normobaric oxygen therapy)
The oxygen concentration will be maintained below 28% and sometimes below 24%. Oxygen concentrations for inhalation in newborns should be maintained below 40% and can only be increased up to 100% in very exceptional cases. The lowest possible concentration of oxygen that is effective should be used to achieve adequate oxygenation. It is recommended to avoid fluctuations in oxygen saturation.
100% oxygen is administered at a flow rate of 7 liters per minute for 15 minutes using a mask. Treatment should be started when the first symptoms occur.
How to use normal pressure oxygen therapy
How to receive high-pressure oxygen therapy
If you use more Medicinal Liquid Oxygen VIVISOL than you should
In case of overdose, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount inhaled.
The toxic effects of oxygen can vary depending on the oxygen pressure inhaled and the duration of exposure. At low pressure(0.5 to 2.0 bars), it is more likely that toxic effects will occur in the lungs (pulmonary area) than in the brain and spinal cord (central nervous system). At high pressure, the opposite occurs.
The effects on the lungs (pulmonary area) include respiratory difficulties, coughing, and chest pain.
The effects on the brain and spinal cord (central nervous system) include tinnitus, auditory and visual disturbances, nausea, dizziness, anxiety, and confusion, muscle cramps, localized (around the eyes, mouth, and forehead), fainting, and convulsions (epileptic seizures).
The ocular effects include blurred vision and reduced peripheral vision ("tunnel vision").
In case of oxygen intoxication due to hyperoxia, oxygen therapy should be reduced or, if possible, interrupted, and treatment of symptoms should be initiated.
If you forget to use Medicinal Liquid Oxygen VIVISOL
Use the oxygen as described in the dosage section of the package leaflet. Do not use a double dose to make up for the forgotten dose. This is because medicinal oxygen could be harmful at high concentrations.
If you stop using Medicinal Liquid Oxygen VIVISOL
Do not stop using this medication on your own initiative. Consult your doctor or pharmacist.
Safety measures for using medicinal oxygen
Oxygen is an oxidizing product and promotes combustion. There should be no smoking or open flames (e.g., pilot lights, stoves, ovens, gas chimneys, sparks, candles, etc.) in the rooms where medicinal oxygen is used, as this increases the risk of fire.
Handle the cylinder with care. Ensure that the gas cylinder does not suffer falls or is exposed to shocks.
If you have any further questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication can cause side effects, although not everyone will experience them.
Very common(may affect more than 1 in 10 people)
With normobaric therapy: In newborns exposed to high oxygen concentrations: eye damage, which can cause vision problems.
With hyperbaric therapy: ear pain, myopia, barotrauma (injuries caused by changes in pressure).
Common(may affect up to 1 in 10 people)
With hyperbaric therapy: Convulsions
Uncommon(may affect up to 1 in 100 people)
With normobaric therapy: Lung collapse (atelectasis).
With hyperbaric therapy: Eardrum rupture
Rare(may affect up to 1 in 1,000 people)
With hyperbaric therapy: Shortness of breath, abnormally low blood sugar levels in diabetic patients.
Frequency not known(cannot be estimated from available data)
With normobaric therapy: Pulmonary toxicity, worsening of excess carbon dioxide in the blood (hypercapnia), dryness of the mucous membrane, local irritation, and inflammation of the mucosa.
With hyperbaric therapy: Difficulty breathing, involuntary muscle contractions, dizziness, hearing impairment, acute serous otitis, ringing or buzzing in the ears (tinnitus), nausea, abnormal behavior, reduced peripheral vision, visual changes, cataracts.
Reporting side effects
If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this package leaflet.
You can also report them directly through the Spanish Medicines Agency's online platform: www.notificaram.es
By reporting side effects, you can help provide more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use the medicinal oxygen after the expiration date stated on the gas cylinder/container/ tank, after the abbreviation EXP. The expiration date is the last day of the month indicated.
Medicinal Liquid Oxygen
Keep the container/tank in a well-ventilated area with a temperature range of -20°C and +50°C.
Keep it away from flammable and combustible materials, heat sources, or fires.
Do not smoke near the container/tank.
Transportation should be carried out in accordance with international regulations for transporting hazardous materials.
Avoid any contact with oils, fats, or hydrocarbons.
Composition of Medicinal Liquid Oxygen VIVISOL
The active ingredient is oxygen, 100% v/v.
It does not contain any other active ingredients.
Product Appearance and Container Content
Medicinal oxygen is a gas for inhalation.
It is supplied in liquid form in a special container.
Oxygen is a colorless, odorless, and tasteless gas.
Liquid oxygen is blue in color.
Nominal Capacity of the Container in Liters | Equivalent Amount of Gaseous Oxygen in m3at 15°C and 1 atm | Weight of the Stored Product (Kg) |
10 L | 8.53 m3 | 11.4 Kg |
20 L | 17.06 m3 | 22.8 Kg |
21 L | 17.91 m3 | 23.94 Kg |
30 L | 25.59 m3 | 34.2 Kg |
31 L | 26.44 m3 | 35.34 Kg |
35 L | 29.85 m3 | 39.9 Kg |
36 L | 30.70 m3 | 41.04 Kg |
37 L | 31.56 m3 | 42.18 Kg |
41 L | 34.97 m3 | 46.74 Kg |
45 L | 38.38 m3 | 51.3 Kg |
46 L | 39.23 m3 | 52.44 Kg |
60 L | 51.18 m3 | 68.4 Kg |
120 L | 102.36 m3 | 136.8 Kg |
160 L | 136.48 m3 | 182.4 Kg |
180 L | 153.54 m3 | 205.2 Kg |
200 L | 170.6 m3 | 228 Kg |
220 L | 187.66 m3 | 250.8 Kg |
230 L | 196.19 m3 | 262.2 Kg |
260 L | 221.78 m3 | 296.4 Kg |
280 L | 238.84 m3 | 319.2 Kg |
300 L | 255.9 m3 | 342 Kg |
320 L | 272.96 m3 | 364.8 Kg |
450 L | 383.85 m3 | 513 Kg |
600 L | 511.8 m3 | 684 Kg |
700 L | 597.1 m3 | 798 Kg |
800 L | 682.4 m3 | 912 Kg |
1000 L | 853 m3 | 1140 Kg |
Medicinal liquid oxygen:
Medicinal liquid oxygen is packaged in mobile cryogenic containers. The mobile cryogenic containers are manufactured with an outer and inner stainless steel container, with vacuum insulation panels between them, and equipped with a filling port and a tube retraction connection.
These containers contain oxygen in a liquid state at very low temperatures.
The content of the containers varies from 10 to 1000 liters.
Each liter of liquid oxygen supplies 853 liters of gaseous oxygen at 15°C and 1 bar.
Only some container sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder
VIVISOL IBÉRICA, S.L.
C/ Yeso, 2
28500 Arganda del Rey (Madrid)
Spain
Manufacturer
Sol B S.R.L.
Zoning Ouest 15
7860 Lessines, Belgium
Or
VIVISOL IBÉRICA, S.L.
C/ Yeso, 2
28500 Arganda del Rey (Madrid)
Spain
Or
MESSER IBERICA DE GASES, S.A.
Autovia Tarragona-Salou, Km 3,800,
Vilaseca, 43480 Tarragona
Spain
Or
MESSER IBERICA DE GASES, S.A.
Pol. Industrial La Granadina III. C/Francia esquina C/Grecia Parcela 11.
San Isidro 03349 Alicante
Spain
Or
SOL FRANCE, SUCURSAL EN ESPAÑA
C/ del Telègraf 17-19, PI SOTA EL MOLI,
Montmeló, 08160 Barcelona
Date of the Last Revision of the Leaflet:September 2020.
This information is intended only for healthcare professionals:
Dosage
The concentration, flow, and duration of treatment must be determined by a doctor, according to the characteristics of each pathology.
Hypoxemia is a disorder in which the arterial partial pressure of oxygen (PaO2) is less than 10 kPa (<70 mmhg). an oxygen pressure level of 8 kpa (55 60 mmhg) leads to respiratory failure.< p>
Hypoxemia is treated by enriching the inhaled air with additional oxygen. The decision to introduce oxygen treatment depends on the degree of hypoxemia and the individual patient's tolerance level.
In all cases, the goal of oxygen treatment is to maintain a PaO2 > 60 mmHg (7.96 kPa) or an arterial oxygen saturation of ≥ 90%.
If oxygen is administered diluted in another gas, the oxygen concentration in the inhaled air (FiO2) must be at least 21%.
Normal pressure oxygen treatment (normobaric oxygen therapy):
Oxygen administration must be carried out with caution. The dose must be adapted to the individual needs of the patient, oxygen pressure must be maintained above 8.0 kPa (or 60 mmHg), and hemoglobin oxygen saturation must be > 90%. It is necessary to regularly monitor arterial oxygen pressure (PaO2) or pulse oximetry (arterial oxygen saturation [SpO2]) and clinical signs. The goal is for the inhaled air to always have the lowest effective oxygen concentration possible, which is the minimum dose to maintain a pressure of 8 kPa (60 mmHg)/saturation > 90%. The administration of high concentrations should be as brief as possible, under strict control of blood gas values.
Oxygen can be safely administered in the following concentrations and for the indicated periods:
Up to 100% for less than 6 hours.
60-70% for 24 hours.
40-50% during the second 24-hour period.
Oxygen is potentially toxic in concentrations above 40% after two days.
Neonates are not included in these guidelines because retrolental fibroplasia occurs with a much lower FiO2. To achieve adequate and appropriate oxygenation in neonates, the lowest effective concentrations should be selected.
The effective oxygen concentration is at least 24%. Normally, a minimum of 30% oxygen is administered to ensure therapeutic concentrations with a safety margin.
Treatment with high oxygen concentration (> 60%) for short periods is indicated in cases of severe asthma crisis, pulmonary thromboembolism, pneumonia, pulmonary fibrosis, etc.
Low oxygen concentration is indicated for the treatment of patients with chronic respiratory failure caused by chronic obstructive respiratory disease or other causes. The oxygen concentration should not exceed 28%, and for some patients, even 24% may be excessive.
It is possible to administer higher oxygen concentrations (in some cases up to 100%), although it is very difficult to obtain concentrations > 60% (or 80% in the case of children) with the use of most administration devices.
The dose must be adapted to the individual needs of the patient, at flows ranging from 1 to 10 liters of gas per minute.
Oxygen should be administered at flows ranging from 0.5 to 2 liters/minute, and it is necessary to adjust the flow rate based on blood gas values. The effective oxygen concentration will be maintained below 28% and sometimes even below 24% in patients with respiratory disorders who depend on hypoxia as a respiratory stimulus.
Treatment is adjusted according to blood gas values. The arterial partial pressure of oxygen (PaO2) should be > 60 mmHg (7.96 kPa), and the arterial oxygen saturation should be ≥ 90%.
The most frequent administration rate is 1 to 3 liters/minute for 15 to 24 hours/day, which also includes paradoxical sleep (the most sensitive period to hypoxemia during the day). During a stable period of the disease, it is recommended to control CO2 concentrations twice every 3 or 4 weeks or 3 times a month, as CO2 concentrations may increase during oxygen administration (hypercapnia).
Oxygen should be administered at a rate ranging from 0.5 to 15 liters/minute, and it is necessary to adjust the flow rate based on blood gas values. In emergency cases, patients with severe respiratory distress require considerably higher doses (up to 60 liters/minute).
If oxygen is mixed with other gases, the fraction of oxygen in the inhaled gas mixture (FiO2) should not fall below 21%. In practice, 30% tends to be the lower limit. If necessary, the fraction of inhaled oxygen can be increased up to 100%.
In exceptional cases, concentrations of up to 100% can be administered to newborns, however, treatment should be closely monitored. The lowest effective concentrations should be used to achieve adequate oxygenation. As a general rule, oxygen concentrations above 40% in the inhaled air should be avoided, taking into account the risk of eye damage (retinopathy) or lung collapse. Arterial oxygen pressure should be closely monitored and maintained below 13.3 kPa (100 mmHg). Fluctuations in oxygen saturation should be avoided. By preventing substantial fluctuations in oxygenation, the risk of eye damage can be reduced. (See also section 4.4).
In the case of cluster headache, 100% oxygen is administered at a flow rate of 7 liters/minute for 15 minutes through a well-fitting facial mask. Treatment should be started in the initial stage of the crisis.
Hypobaric oxygen treatment:
The doses and pressure must always be adapted to the patient's clinical picture, and treatment can only be administered after medical consultation. However, some recommendations based on current knowledge are as follows:
Hypobaric oxygen treatment is administered at pressures above 1 atmosphere (1.013 bar), between 1.4 and 3.0 atmospheres (normally between 2 and 3 atmospheres). Hypobaric oxygen is administered in a special pressurized room. Treatment with oxygen at elevated pressures can also be administered through a well-fitting facial mask with a hood that covers the head or through a tracheal tube.
Each treatment session lasts from 45 to 300 minutes, depending on the indication.
Sometimes, acute hypobaric oxygen treatment lasts only one or two sessions, while chronic treatment can last up to 30 sessions or more. If necessary, sessions can be repeated two or three times a day.
If carbon monoxide poisoning occurs, oxygen should be administered as soon as possible in high concentrations (100%), until the carboxyhemoglobin concentration falls below dangerous levels (around 5%). Hyperbaric oxygen (from 3 atmospheres) is indicated in patients with acute CO poisoning or who have been exposed to intervals of ≥24 hours. Additionally, pregnant patients, patients with loss of consciousness, or those with higher carboxyhemoglobin levels justify hyperbaric oxygen treatment. Normobaric oxygen should not be used between multiple hyperbaric oxygen treatments, as it may contribute to toxicity. Hyperbaric oxygen also appears to have potential for deferred treatment of CO poisoning using multiple low-dose oxygen treatments.
Fast treatment at 2.8 atmospheres is recommended, with up to 10 repetitions if symptoms persist.
In this case, the doses are adapted to the patient's clinical picture and blood gas values. The target values are: PaO2 > 8 kPa or 60 mmHg, hemoglobin saturation > 90%.
Treatment of radiation lesions with hyperbaric oxygen typically consists of daily sessions of 90 to 120 minutes at 2.0 to 2.5 atmospheres for about 40 days.
Treatment of 90 minutes at 3.0 atmospheres is recommended during the first 24 hours, followed by twice-daily treatments for 4 or 5 days, until clinical improvement is observed.
Method of Administration
Oxygen is administered through the inhaled air, preferably with equipment designed for this purpose (e.g., a nasal catheter or mask). Through this equipment, oxygen is administered with the inhaled air. Subsequently, the gas and excess oxygen exit the patient with the exhaled air and mix with the ambient air (non-rebreathing system). In many cases, during anesthesia, special systems with a rebreathing or recycling system are used so that the exhaled air is inhaled again (rebreathing system).
If the patient is unable to breathe on their own, artificial respiratory assistance can be provided. On the other hand, oxygen can be injected directly into the bloodstream through the so-called oxygenator. The application of extracorporeal gas exchange devices facilitates oxygenation and decarboxylation without the damage associated with aggressive mechanical ventilation strategies. The oxygenator, which acts as an artificial lung, provides better oxygen transfer, and therefore, blood gas levels are maintained within clinically acceptable ranges. After recovery of lung function, the extracorporeal blood and gas flow are reduced and eventually stopped. This occurs, for example, during cardiac surgery using a cardiopulmonary bypass system, as well as in other circumstances that require extracorporeal circulation, including acute respiratory failure.
Hyperbaric oxygen treatment is administered in a special pressurized room where the ambient pressure can be multiplied up to three times the atmospheric pressure. Hyperbaric oxygen treatment can also be administered through a well-fitting facial mask with a hood that covers the head or through a tracheal tube.
General
Medical gases should only be used for medical purposes.
Different types and qualities of gases should be separated from each other.
Full and empty containers should be stored separately.
Never use grease, oil, or similar substances to lubricate stuck or difficult-to-connect screw threads.
Handle valves and devices with clean hands and without any type of grease (hand cream, etc.).
Only use standard equipment designed for medicinal oxygen.
Preparation for Use
Only use dose administration devices designed for medicinal oxygen.
Check that the automatic coupling and administration device are clean and that the gaskets function properly. Never use pressure tools/regulators designed for manual connection, as this can damage the coupling.
Slowly open the valve: at least half a turn.
Check for leaks according to the instructions provided with the regulator.
In case of a leak, close the valve and disconnect the regulator. Mark the defective containers, store them separately, and return them to the supplier.
Use
It is strictly forbidden to smoke and start fires in the rooms where oxygen treatment is carried out.
If not in use or in case of fire, the device should be closed.
Take it to a safe place in case of fire.
Larger containers should be transported using specific vehicles for this purpose.
Pay special attention to connected devices so that they do not become disconnected accidentally.
When the container is empty, the gas flow will decrease. Close the outlet valve and remove the couplings after releasing the pressure.
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/